Jonathan Terrett
Chief Tech/Sci/R&D Officer bij CRISPR THERAPEUTICS AG
Profiel
Jonathan Alexander Terrett is currently the Head of Research at CRISPR Therapeutics AG.
He previously worked as a Director at Medarex, Inc., Director at Oxford BioTherapeutics Ltd., Director at Oxford GlycoSciences Plc, Director at Celltech R&D Ltd., Principal at Smithkline Beecham Plc, and Vice President of Oncology Discovery at CytomX Therapeutics Holdings LLC.
He obtained his undergraduate degree from The University of Sheffield and his doctorate degree from The University of Nottingham in 1996.
Actieve functies van Jonathan Terrett
Bedrijven | Functie | Begin |
---|---|---|
CRISPR THERAPEUTICS AG | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Jonathan Terrett
Bedrijven | Functie | Einde |
---|---|---|
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Chief Tech/Sci/R&D Officer | 29-07-2013 |
Celltech R&D Ltd.
Celltech R&D Ltd. Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, Celltech R & D Ltd. is a British company that engages in drug discovery and development. The private company is based in Slough, UK. Celltech R&D Ltd. was founded in 1980. | Director/Board Member | - |
CytomX Therapeutics Holdings LLC
CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Corporate Officer/Principal | - |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Corporate Officer/Principal | - |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Director/Board Member | - |
Opleiding van Jonathan Terrett
The University of Sheffield | Undergraduate Degree |
The University of Nottingham | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CRISPR THERAPEUTICS AG | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
CytomX Therapeutics Holdings LLC
CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Health Technology |
Celltech R&D Ltd.
Celltech R&D Ltd. Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, Celltech R & D Ltd. is a British company that engages in drug discovery and development. The private company is based in Slough, UK. Celltech R&D Ltd. was founded in 1980. | Commercial Services |